Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 3
2017 2
2018 1
2021 1
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Results by year

Filters applied: . Clear all
Page 1
Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells.
Leung SS, Borg DJ, McCarthy DA, Boursalian TE, Cracraft J, Zhuang A, Fotheringham AK, Flemming N, Watkins T, Miles JJ, Groop PH, Scheijen JL, Schalkwijk CG, Steptoe RJ, Radford KJ, Knip M, Forbes JM. Leung SS, et al. Among authors: flemming n. Diabetes. 2022 Sep 1;71(9):1994-2008. doi: 10.2337/db22-0177. Diabetes. 2022. PMID: 35713929 Free PMC article.
T-Cell Expression and Release of Kidney Injury Molecule-1 in Response to Glucose Variations Initiates Kidney Injury in Early Diabetes.
Forbes JM, McCarthy DA, Kassianos AJ, Baskerville T, Fotheringham AK, Giuliani KTK, Grivei A, Murphy AJ, Flynn MC, Sullivan MA, Chandrashekar P, Whiddett R, Radford KJ, Flemming N, Beard SS, D'Silva N, Nisbet J, Morton A, Teasdale S, Russell A, Isbel N, Jones T, Couper J, Healy H, Harris M, Donaghue K, Johnson DW, Cotterill A, Barrett HL, O'Moore-Sullivan T. Forbes JM, et al. Among authors: flemming n. Diabetes. 2021 Aug;70(8):1754-1766. doi: 10.2337/db20-1081. Epub 2021 Mar 18. Diabetes. 2021. PMID: 34285121 Free PMC article.
Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes.
Ward MS, Flemming NB, Gallo LA, Fotheringham AK, McCarthy DA, Zhuang A, Tang PH, Borg DJ, Shaw H, Harvie B, Briskey DR, Roberts LA, Plan MR, Murphy MP, Hodson MP, Forbes JM. Ward MS, et al. Among authors: flemming nb. Sci Rep. 2017 Nov 9;7(1):15190. doi: 10.1038/s41598-017-15589-x. Sci Rep. 2017. PMID: 29123192 Free PMC article.
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
Gallo LA, Ward MS, Fotheringham AK, Zhuang A, Borg DJ, Flemming NB, Harvie BM, Kinneally TL, Yeh SM, McCarthy DA, Koepsell H, Vallon V, Pollock C, Panchapakesan U, Forbes JM. Gallo LA, et al. Among authors: flemming nb. Sci Rep. 2016 May 26;6:26428. doi: 10.1038/srep26428. Sci Rep. 2016. PMID: 27226136 Free PMC article.
Erratum: Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
Gallo LA, Ward MS, Fotheringham AK, Zhuang A, Borg DJ, Flemming NB, Harvie BM, Kinneally TL, Yeh SM, McCarthy DA, Koepsell H, Vallon V, Pollock C, Panchapakesan U, Forbes JM. Gallo LA, et al. Among authors: flemming nb. Sci Rep. 2016 Jul 7;6:28124. doi: 10.1038/srep28124. Sci Rep. 2016. PMID: 27389496 Free PMC article. No abstract available.